UBS Group Cuts Adient (NYSE:ADNT) Price Target to $29.00

Adient (NYSE:ADNT) had its price objective cut by stock analysts at UBS Group from $34.00 to $29.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s price objective points to a potential upside of 50.13% from the stock’s current price.

A number of other research analysts have also recently commented on ADNT. BNP Paribas Exane raised Adient from a “neutral” rating to an “outperform” rating and set a $26.00 target price on the stock in a research note on Thursday, July 30th. Wells Fargo & Company raised their price objective on Adient from $28.00 to $32.00 and gave the company an “overweight” rating in a report on Thursday, June 25th. Barclays upped their target price on Adient from $26.00 to $29.00 and gave the stock an “equal weight” rating in a research note on Monday, May 11th. Weiss Ratings raised shares of Adient from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 13th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $28.00 price objective on shares of Adient in a report on Thursday. Six investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Adient currently has a consensus rating of “Hold” and a consensus target price of $27.30.

Adient Price Performance

ADNT traded down $1.20 on Thursday, reaching $19.32. The company had a trading volume of 577,943 shares, compared to its average volume of 1,030,266. Adient has a 52-week low of $17.68 and a 52-week high of $27.32. The company has a market cap of $1.51 billion, a price-to-earnings ratio of 27.19, a P/E/G ratio of 0.41 and a beta of 1.52. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.91 and a current ratio of 1.10. The business has a 50 day simple moving average of $20.74 and a 200 day simple moving average of $21.59.

Adient (NYSE:ADNT) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.08). The company had revenue of $3.93 billion during the quarter, compared to the consensus estimate of $3.71 billion. Adient had a return on equity of 7.28% and a net margin of 0.39%.Adient’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.45 EPS. As a group, sell-side analysts anticipate that Adient will post 2.13 EPS for the current year.

Insider Transactions at Adient

In related news, EVP Heather M. Tiltmann sold 22,000 shares of the stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $22.71, for a total value of $499,620.00. Following the completion of the transaction, the executive vice president directly owned 110,886 shares of the company’s stock, valued at $2,518,221.06. This represents a 16.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.94% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Adient

Institutional investors and hedge funds have recently made changes to their positions in the company. Parallel Advisors LLC lifted its position in Adient by 19.4% in the 1st quarter. Parallel Advisors LLC now owns 3,186 shares of the company’s stock valued at $64,000 after acquiring an additional 517 shares in the last quarter. Glenmede Trust Co. NA bought a new stake in shares of Adient in the first quarter worth approximately $274,000. Segall Bryant & Hamill LLC bought a new stake in shares of Adient in the first quarter worth approximately $1,404,000. Bank of America Corp DE raised its holdings in shares of Adient by 61.7% during the first quarter. Bank of America Corp DE now owns 792,543 shares of the company’s stock valued at $16,017,000 after purchasing an additional 302,538 shares during the last quarter. Finally, Amundi lifted its position in Adient by 21.7% during the first quarter. Amundi now owns 143,022 shares of the company’s stock valued at $2,890,000 after purchasing an additional 25,541 shares during the period. Institutional investors own 92.44% of the company’s stock.

Adient News Roundup

Here are the key news stories impacting Adient this week:

• Positive Sentiment: Revenue rose 4.3% year over year to $3.93 billion, exceeding analysts’ $3.71 billion estimate. Growth was led by the Americas and Asia, while EMEA sales declined. Adient quarterly earnings report
• Positive Sentiment: Adient reaffirmed its fiscal 2026 earnings and free-cash-flow outlook and projected approximately $15.0 billion in revenue, above the $14.8 billion consensus estimate. Adient reports third quarter financial results
• Positive Sentiment: Cash generation improved: non-GAAP free cash flow increased to $138 million from $115 million a year earlier, while quarterly operating cash flow was $205 million. The company also repurchased $30 million of stock.
• Neutral Sentiment: Management’s earnings-call materials emphasized execution and maintained the full-year outlook, but investors may want additional clarity on the path to margin improvement and debt reduction. Adient Q3 2026 earnings call transcript
• Negative Sentiment: Adjusted EPS was $0.48, below the $0.53-$0.56 analyst consensus, although it improved from $0.45 a year ago. Net income attributable to Adient fell to $25 million from $36 million, and diluted EPS declined to $0.32 from $0.43. Adient misses Q3 earnings estimates
• Negative Sentiment: Profitability remains thin, with a reported net margin of just 0.39%, while total debt stood at approximately $2.39 billion against $924 million of cash. Recent insider activity also consisted of sales rather than purchases.

About Adient

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.